Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 211

1.

Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.

Wilhelmson S, Reepalu A, Balcha TT, Jarso G, Björkman P.

Glob Health Action. 2016 Jan 12;9:29943. doi: 10.3402/gha.v9.29943. eCollection 2016.

2.

Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.

Wolff M, Shepherd BE, Cortés C, Rebeiro P, Cesar C, Wagner Cardoso S, Pape JW, Padgett D, Sierra-Madero J, Echevarria J, McGowan CC; Caribbean, Central and South America Network for HIV Epidemiology.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):102-10. doi: 10.1097/QAI.0000000000000817.

PMID:
26761273
3.

Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994-2012.

Ocampo JM, Plankey M, Zou K, Collmann J, Wang C, Young MA, Liu C, Ripple JA, Kassaye S.

BMC Public Health. 2015 Dec 22;15:1277. doi: 10.1186/s12889-015-2653-x.

4.

Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.

Abioye AI, Soipe AI, Salako AA, Odesanya MO, Okuneye TA, Abioye AI, Ismail KA, Omotayo MO.

AIDS Care. 2015;27(12):1468-86. doi: 10.1080/09540121.2015.1114994.

PMID:
26695132
5.

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.

Castelnuovo B, Kiragga A, Musaazi J, Sempa J, Mubiru F, Wanyama J, Wandera B, Kamya MR, Kambugu A.

PLoS One. 2015 Dec 7;10(12):e0142722. doi: 10.1371/journal.pone.0142722. eCollection 2015.

6.

Outcome of patients on second line antiretroviral therapy under programmatic condition in India.

Chakravarty J, Sundar S, Chourasia A, Singh PN, Kurle S, Tripathy SP, Chaturbhuj DN, Rai M, Agarwal AK, Mishra RN, Paranjape RS.

BMC Infect Dis. 2015 Nov 14;15:517. doi: 10.1186/s12879-015-1270-8.

7.

Lack of awareness of treatment failure among HIV-1-infected patients in Guinea-Bissau - a retrospective cohort study.

Jespersen S, Hønge BL, Medina C, da Silva Té D, Correira FG, Laursen AL, Erikstrup C, Østergaard L, Wejse C; Bissau HIV Cohort study group.

J Int AIDS Soc. 2015 Sep 29;18:20243. doi: 10.7448/IAS.18.1.20243. eCollection 2015.

8.

Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis.

Hemkens LG, Ewald H, Santini-Oliveira M, Bühler JE, Vuichard D, Schandelmaier S, Stöckle M, Briel M, Bucher HC.

HIV Clin Trials. 2015 Oct;16(5):178-89. doi: 10.1179/1945577115Y.0000000004. Review.

PMID:
26395328
9.

Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.

Boender TS, Hoenderboom BM, Sigaloff KC, Hamers RL, Wellington M, Shamu T, Siwale M, Labib Maksimos EE, Nankya I, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Ondoa P, Rinke de Wit TF.

Clin Infect Dis. 2015 Dec 1;61(11):1749-58. doi: 10.1093/cid/civ656. Epub 2015 Aug 3.

PMID:
26240203
10.

High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection.

Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):395-402. doi: 10.1097/QAI.0000000000000617.

PMID:
26115437
11.

Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003-2014.

Huang P, Tan J, Ma W, Zheng H, Lu Y, Wang N, Peng Z, Yu R.

BMJ Open. 2015 May 22;5(5):e007508. doi: 10.1136/bmjopen-2014-007508.

12.

Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.

Ngarina M, Kilewo C, Karlsson K, Aboud S, Karlsson A, Marrone G, Leyna G, Ekström AM, Biberfeld G.

BMC Infect Dis. 2015 Apr 8;15:175. doi: 10.1186/s12879-015-0914-z.

13.

Dynamic Visual Display of Treatment Response in HIV-Infected Adults.

Edwards JK, Cole SR, Martin JN, Moore R, Mathews WC, Kitahata M, Eron JJ, Saag M, Mugavero MJ; CNICS Investigators.

Clin Infect Dis. 2015 Jul 1;61(1):e1-4. doi: 10.1093/cid/civ262. Epub 2015 Apr 1.

14.

Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data.

Vanobberghen FM, Kilama B, Wringe A, Ramadhani A, Zaba B, Mmbando D, Todd J.

Trop Med Int Health. 2015 Jul;20(7):880-92. doi: 10.1111/tmi.12507. Epub 2015 Apr 2.

15.

Predictors of immunological failure and determinants of suboptimal CD4 testing among adults with HIV on first-line antiretroviral therapy in Andhra Pradesh, India, 2008-2011.

Allam RR, Murhekar MV, Bhatnagar T, Uthappa CK, Nalini C, Rewari BB, Mehendale SM.

Trans R Soc Trop Med Hyg. 2015 May;109(5):325-33. doi: 10.1093/trstmh/trv018. Epub 2015 Mar 15.

PMID:
25778736
16.

HIV patients' decision of switching to second-line antiretroviral therapy in India.

de Mello-Sampayo F.

AIDS Care. 2015;27(7):900-6. doi: 10.1080/09540121.2015.1015480. Epub 2015 Feb 27.

PMID:
25723906
17.

The Cologne-Bonn cohort: lessons learned.

Rockstroh JK.

Infection. 2015 Apr;43(2):135-9. doi: 10.1007/s15010-015-0745-2. Epub 2015 Feb 24. Review.

PMID:
25708018
18.

Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational database.

Boettiger DC, Nguyen VK, Durier N, Bui HV, Heng Sim BL, Azwa I, Law M, Ruxrungtham K.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):186-95. doi: 10.1097/QAI.0000000000000411.

19.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk